Stay updated on Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page.

Latest updates to the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe revision stamp in the page footer was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2. No changes to study data, eligibility criteria, or navigation.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed, which are minor UI metadata changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page now includes a glossary toggle and minor metadata and wording updates (Last Update Submitted that Met QC Criteria, No FEAR Act Data capitalization, and Revision: v3.4.0) compared with the previous version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check54 days agoChange DetectedAdded a visible 'Last Update Posted' timestamp and removed the 'Last Update Posted (Estimated)' label in the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedA minor revision update from v3.3.3 to v3.3.4 is shown, with no visible changes to study details or page layout. No user-facing content was altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page.